A new study from a pro-abortion group shows that chemical pills were used in most American abortions for the first time in 2020. The Guttmacher Institute found in its report published last month that 54 percent of abortions were induced by chemical pills that year, up from 39 percent in 2017.
The FDA approved Mifepristone in 2000. The drug is prescribed to terminate a growing fetus through the 10th week of pregnancy but has medical complications at four times that of those in surgical abortions.
The use of the drug is expected to continue to increase because of deregulation by the Biden administration. The FDA removed the requirement for an in-person doctor visit to obtain a prescription for the drug last December. That move came in response to a resolution backed by Planned Parenthood and signed by over 70 Democratic lawmakers last summer demanding that prescriptions be made available through virtual telemedicine consultations.
Sue Liebel with the pro-life advocacy group Susan B. Anthony List said the recent deregulation is an example of the close relationship between the Democratic Party and the abortion industry. She said the administration is now endangering the health of women and unborn children to secure profits for the abortion industry. She added that FDA is “ironically ignoring the science about the serious risks of chemical abortion.”
Mifepristone manufacturers were no longer required to report adverse medical events from using the drug not resulting in death, including hemorrhages and ectopic pregnancies under the Obama administration in 2016.
Charlotte Lozier Institute Senior Researcher Tessa Longbons said that the FDA should not rely solely on data from the companies that profit from drug sales to issue regulations. Studies that include emergency room data in addition to self-reported data indicate complication rates up to 10 times greater than those relied on by the FDA.
She added that the Guttmacher study provides an incomplete analysis because it also relies on data reported by abortion providers. The study leaves out data from California, Maryland and New Hampshire, accounting for an estimated one-fifth of American abortion procedures.
State regulations and federal deregulations of various abortion procedures have been very active over the last year. The Supreme Court prepares to issue its final decision in a potential landmark abortion case this term, Dobbs v. Jackson Women’s Health Organization. The court has been asked in Dobbs to expressly overturn the 1973 case that prohibits states from enacting most abortion restrictions, Roe v. Wade. The decision in Dobbs is expected between now and the end of the court’s current term in June.